GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cresco Labs Inc (FRA:6CQ) » Definitions » Gross-Profit-to-Asset %

Cresco Labs (FRA:6CQ) Gross-Profit-to-Asset % : 25.27% (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Cresco Labs Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Cresco Labs's annualized Gross Profit for the quarter that ended in Dec. 2024 was €321.0 Mil. Cresco Labs's average Total Assets over the quarter that ended in Dec. 2024 was €1,270.2 Mil. Therefore, Cresco Labs's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 was 25.27%.


Cresco Labs Gross-Profit-to-Asset % Historical Data

The historical data trend for Cresco Labs's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cresco Labs Gross-Profit-to-Asset % Chart

Cresco Labs Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.67 27.78 25.02 24.25 27.40

Cresco Labs Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 27.59 27.18 28.03 26.86 25.27

Competitive Comparison of Cresco Labs's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Cresco Labs's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cresco Labs's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cresco Labs's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Cresco Labs's Gross-Profit-to-Asset % falls into.


;
;

Cresco Labs Gross-Profit-to-Asset % Calculation

Cresco Labs's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2024 )/( (Total Assets (A: Dec. 2023 )+Total Assets (A: Dec. 2024 ))/ count )
=348.054/( (1245.714+1294.364)/ 2 )
=348.054/1270.039
=27.40 %

Cresco Labs's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2024 )/( (Total Assets (Q: Sep. 2024 )+Total Assets (Q: Dec. 2024 ))/ count )
=320.98/( (1246.022+1294.364)/ 2 )
=320.98/1270.193
=25.27 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Dec. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Cresco Labs Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Cresco Labs's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Cresco Labs Business Description

Traded in Other Exchanges
Address
600 W. Fulton Street, Suite 800, Chicago, IL, USA, 60661
Cresco Labs Inc is a vertically-integrated multi-state cannabis operator in the United States licensed to cultivate, manufacture and sell retail and medical cannabis products through Sunnyside, Cresco Labs' national dispensary brand and others. The company operates in one segment, the cultivation, manufacturing, distribution and sale of cannabis.

Cresco Labs Headlines

No Headlines